Resonance Raman studies of catecholate and phenolate complexes of recombinant human tyrosine hydroxylase.

Human tyrosine hydroxylase isoform 1 (hTH1) was expressed in Escherichia coli, purified as the apoenzyme, and reconstituted with iron. The resonance Raman spectra of hTH1 complexed with dopamine, noradrenaline, tyramine, and catechol have been studied and compared to those obtained for TH isolated from bovine adrenal glands or rat phaeochromocytoma tissue. A TH-phenolate complex is reported for the first time. Using dopamine selectively 18O-labeled in the 3-position or both 3- and 4-hydroxy positions, we have been able to assign unambiguously the origin of the low-frequency vibration bands: the band at 631 cm-1 involves the oxygen in the 4-position; the band at 592 cm-1 involves the oxygen in the 3-position, and the band around 528 cm-1 is shifted by both, suggesting a chelated mode vibration. A small shift of the 1275 cm-1 band and no shift of the 1320 cm-1 band were observed, showing that those two bands involve essentially ring vibrations of the catecholate moiety, rather than the C--O stretching vibration as previously suggested. The spectrum of the catechol-d6-hTH1 complex confirms this assignment. The resonance Raman spectra of the 54Fe, 56Fe, or 57Fe isotope-containing enzymes complexed with dopamine are virtually identical, showing that the component of the iron in the approximately 600 cm-1 vibrations is too small to be observed. These results provide a better understanding of the Raman properties of iron-catecholate complexes in this enzyme, as well as in other metalloproteins and model compounds.

[1]  T. Flatmark,et al.  Resonance Raman studies on the blue-green-colored bovine adrenal tyrosine 3-monooxygenase (tyrosine hydroxylase). Evidence that the feedback inhibitors adrenaline and noradrenaline are coordinated to iron. , 1988, The Journal of biological chemistry.

[2]  T. Flatmark,et al.  Evidence from EPR spectroscopy that phosphorylation of Ser‐40 in bovine adrenal tyrosine hydroxylase facilitates the reduction of high‐spin Fe(III) under turnover conditions , 1989 .

[3]  H. Wilson The vapor phase infrared spectra of hydroquinone, pyrocatechol, and resorcinol , 1974 .

[4]  S. Benkovic,et al.  Catecholate LMCT bands as probes for the active sites of nonheme iron oxygenases , 1988 .

[5]  M. Nelson Catecholate complexes of ferric soybean lipoxygenase 1 , 1988 .

[6]  N. Yu,et al.  Laser-excited Raman spectroscopy of biomolecules. I. Native lysozyme and its constituent amino acids. , 1970, Journal of molecular biology.

[7]  P. Fitzpatrick Steady-state kinetic mechanism of rat tyrosine hydroxylase. , 1991, Biochemistry.

[8]  S. Udenfriend,et al.  Decrease in Adrenal Tyrosine Hydroxylase and Increase in Norepinephrine Synthesis in Rats Given L-Dopa , 1971, Science.

[9]  J. Mallet,et al.  Recombinant human tyrosine hydroxylase isozymes. Reconstitution with iron and inhibitory effect of other metal ions. , 1991, European journal of biochemistry.

[10]  R. Roskoski,et al.  Inactivation of phosphorylated rat tyrosine hydroxylase by ascorbate in vitro. , 1993, European journal of biochemistry.

[11]  W. Griffith,et al.  Vibrational spectra of catechol, catechol-d2 and -d6 and the catecholate monoanion , 1991 .

[12]  S. Udenfriend,et al.  Inhibitors of purified beef adrenal tyrosine hydroxylase. , 1965, Biochemical pharmacology.

[13]  Y. Moro-oka,et al.  A reaction mimic of tyrosine hydroxylase: hydroxylation of a phenoxo ferric complex to a catecholato complex with mCPBA , 1993 .

[14]  J. Mallet,et al.  The incorporation of divalent metal ions into recombinant human tyrosine hydroxylase apoenzymes studied by intrinsic fluorescence and 1H-NMR spectroscopy. , 1992, European journal of biochemistry.

[15]  T. Flatmark,et al.  Phenylalanine as substrate for tyrosine hydroxylase in bovine adrenal chromaffin cells. , 1990, The Biochemical journal.

[16]  P. Aisen,et al.  Characterization of pink and purple uteroferrin by resonance Raman and CD spectroscopy. , 1982, The Journal of biological chemistry.

[17]  J. Mallet,et al.  Regulation of recombinant human tyrosine hydroxylase isozymes by catecholamine binding and phosphorylation. Structure/activity studies and mechanistic implications. , 1992, European journal of biochemistry.

[18]  T. Flatmark,et al.  Interaction of substrate and pterin cofactor with the metal of human tyrosine hydroxylase as determined by 1H-NMR. , 1993, Advances in experimental medicine and biology.

[19]  T. Flatmark,et al.  Soluble tyrosine hydroxylase (tyrosine 3-monooxygenase) from bovine adrenal medulla: large-scale purification and physicochemical properties. , 1988, Biochimica et biophysica acta.

[20]  J. Mallet,et al.  Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. , 1991, The Journal of biological chemistry.

[21]  T. Spiro Resonance Raman spectroscopy. New structure probe for biological chromophores , 1974 .

[22]  A. Sjoerdsma,et al.  ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. , 1965, The Journal of pharmacology and experimental therapeutics.

[23]  P. Cohen,et al.  Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. , 1993, European journal of biochemistry.

[24]  C. Tyson 4-Nitrocatechol as a colorimetric probe for non-heme iron dioxygenases. , 1975, The Journal of biological chemistry.

[25]  T. Flatmark,et al.  Conformation and interaction of phenylalanine with the divalent cation at the active site of human recombinant tyrosine hydroxylase as determined by proton NMR. , 1993, Biochemistry.

[26]  J. Kelsoe,et al.  Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAs. , 1987, Biochemistry.

[27]  K. Nagai,et al.  Resonance raman studies of hemoglobins M: evidence for iron-tyrosine charge-transfer interactions in the abnormal subunits of Hb M Boston and Hb M Iwate. , 1983, Biochemistry.

[28]  L. Que,et al.  Model studies of iron―tyrosinate proteins , 1985 .

[29]  Thomas G. Spiro,et al.  Biological applications of Raman spectroscopy , 1987 .

[30]  B. Sjöberg,et al.  Dioxygen is the source of the mu-oxo bridge in iron ribonucleotide reductase. , 1994, The Journal of biological chemistry.

[31]  E. Solomon,et al.  Spectroscopic studies of the electronic structure of iron(III) tris(catecholates) , 1991 .

[32]  S. Benkovic,et al.  Mechanism of oxygen activation by tyrosine hydroxylase. , 1987, Biochemistry.

[33]  J. Haavik,et al.  pH‐dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation of Ser‐40 , 1990, FEBS letters.

[34]  L. Que Metalloproteins with phenolate coordination , 1983 .

[35]  James C. Davis,et al.  Spectroscopic and magnetic studies of the purple acid phosphatase from bovine spleen , 1987 .

[36]  J. Mallet,et al.  A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics , 1987, Nature.

[37]  T. Spiro,et al.  Electronic and resonance Raman spectra of iron(III) complexes of enterobactin, catechol, and N-methyl-2,3-dihydroxybenzamide. , 1978, Biochemistry.

[38]  J. Thibault,et al.  Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40. , 1992, The Biochemical journal.